Immune monitoring technology primer

Conclusions Clinical validation of immunology biomarkers can be demanding both in terms of time and resources, and careful planning and study design are critical.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research

Related Links:

Longaker Pancreatic cancer is the 4th leading cause of cancer deaths in the United States. The pancreatic cancer phenotype is primarily a consequence of oncogenes disturbing the resident pancreas parenchymal cell repair program. Many solid tumor types including pancreatic cancer have severe tumor fibrosis called desmoplasia. Desmoplastic stroma is coopted by the tumor as a support structure and CAFs aid in tumor growth, invasion, and metastases. This stroma is caused by cancer associated fibroblasts (CAFs), which lay down extensive connective tissue in and around the tumor cells. CAFs represent a heterogeneous populat...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
This article aims to provide an overview of the efficacy and safety outcomes with durvalumab in patients with stage III NSCLC and identify management strategies for potential adverse events (AEs). METHODS: A review of published literature and guidelines was performed to evaluate durvalumab clinical outcomes and AE management strategies. FINDINGS: Durvalumab has established efficacy in patients with unresectable stage III NSCLC and is now the standard of care following CRT. Nurses need to be trained to recognize potential immune-related AEs in patients treated with immune checkpoint inhibitors. PMID: 32...
Source: Clinical Journal of Oncology Nursing - Category: Nursing Authors: Tags: Clin J Oncol Nurs Source Type: research
sco Inflammatory cells are major players in the onset of cancer. The degree of inflammation and type of inflammatory cells in the tumor microenvironment (TME) are responsible for tilting the balance between tumor progression and regression. Cancer-related inflammation has also been shown to influence the efficacy of conventional therapy. Mononuclear phagocytes (MPs) represent a major component of the inflammatory circuit that promotes tumor progression. Despite their potential to activate immunosurveillance and exert anti-tumor responses, MPs are subverted by the tumor to support its growth, immune evasion, and spread....
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research
AbstractSkin cancers remain the most common group of cancers globally, and the incidence continues to rise. Although localized skin cancers tend to have excellent outcomes following surgical excisions, the less common cases that become surgically unresectable or metastatic have been associated with poor prognosis and suboptimal treatment responses to cytotoxic chemotherapy. Development of monoclonal antibodies to programmed cell death-1 receptor and its ligand (PD-1/PD-L1) have transformed the management of metastatic melanoma, squamous cell carcinoma, and Merkel cell carcinoma. These agents, as monotherapies, are associat...
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research
Authors: Hung LVM, Ngo HT, Van Pham P Abstract The idea of utilizing the human immune system to eradicate tumors has been successfully practiced for the past decades, as reported in multiple published studies. Among cancer types, non-small cell lung cancer (NSCLC) is considered the most lethal type, leading to the necessity of finding an effective treatment for this category of cancer. Building on the success of basic and preclinical studies, numerous clinical trials of cytokine-induced killer (CIK) cells or chimera antigen receptor (CAR) T cells for NSCLC therapy have been reported. In this review paper, we will s...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
Conditions:   Cancer;   COVID;   Solid Tumor;   Social Inequality;   French National Cohort;   Chemotherapy;   Immunotherapy;   Surgery;   Radiotherapy Intervention:   Sponsors:   Federation Francophone de Cancerologie Digestive;   ARCAGY/ GINECO GROUP;   GERCOR - Multidisciplinary Oncology Cooperative Group;   GORTEC;   IFCT;   Association de Neuro-Oncologues d’Expression Francaise Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Contributors : Lawrence P Andrews ; Anthony R Cillo ; Dario A VignaliSeries Type : Expression profiling by high throughput sequencingOrganism :Mechanisms of resistance to cancer immunotherapy remain poorly understood. Lymphocyte Activation Gene-3 (LAG3) signaling is regulated by A Disintegrin And Metalloprotease-10 (ADAM10) and ADAM17-mediated cell surface shedding. We developed and utilized mutant mice expressing a metalloprotease-resistance version of LAG3 that can be selectively expressed in T cell subsets. We sorted live T cells from tumors of mice bearing MC38 tumors following 3 treatments with either anti-PD1 or IgG ...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Source Type: research
(European Society for Medical Oncology) Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory studies reported at the ESMO Breast Cancer Virtual Meeting 2020.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Publication date: July 2020Source: Biomedicine &Pharmacotherapy, Volume 127Author(s): Jiajia Hu, Zhengting Wang, Zhengxi Chen, Ao Li, Jing Sun, Minhua Zheng, Jibo Wu, Tianli Shen, Ju Qiao, Lin Li, Biao Li, Dianqing Wu, Qian Xiao
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Publication date: August 2020Source: Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1874, Issue 1Author(s): Dan Liu, Xuan Zhao, Anqun Tang, Xiyue Xu, Shuci Liu, Li Zha, Wen Ma, Junnian Zheng, Ming Shi
Source: Biochimica et Biophysica Acta (BBA) Reviews on Cancer - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Biotechnology | Cancer | Cancer & Oncology | Immunotherapy | Statistics | Study